Hypoalbuminemia Terminated Phase 3 Trials for Thalidomide (DB01041)

Also known as: Hypoalbuminaemia / Hypoalbuminemia (finding)

IndicationStatusPhase
DBCOND0001670 (Hypoalbuminemia)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00529633The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis PatientsTreatment